US FDA approves Regeneron’s ultra-rare blood disease drug
By Pratik Jain (Reuters) -Regeneron Pharmaceuticals said on Friday the U.S. health regulator approved its...
By Pratik Jain (Reuters) -Regeneron Pharmaceuticals said on Friday the U.S. health regulator approved its...
By Medha Singh (Reuters) -VinFast shares slumped for a third straight session on Friday, with...
By Nichola Groom (Reuters) -The United States on Friday finalized a decision to impose import...
By Zeba Siddiqui SAN FRANCISCO (Reuters) -Google-owned U.S. cybersecurity firm Mandiant said on Thursday it...
By Bianca Flowers and Shivansh Tiwary (Reuters) -Deere & Co breezed past Wall Street estimates...
(Reuters) – Moderna said on Thursday an initial study data showed its updated COVID-19 vaccine...
By Jaspreet Singh and Max A. Cherney (Reuters) -Semiconductor equipment maker Applied Materials on Thursday...
By Daniel Wiessner (Reuters) – A U.S. judge in Florida on Thursday declined to block...
By Lisa Richwine and Dawn Chmielewski LOS ANGELES (Reuters) – The striking Writers Guild of...
By Ernest Scheyder (Reuters) – Automaker Stellantis said it would invest more than $100 million...